Review of 2022 PSOGI/RENAPE Consensus on HIPEC
Shigeki Kusamura, Aditi Bhatt, Kurt Van der Speeten, Vahan Képénékian, Martin Hübner, Clarisse Eveno, Ignace H. J. T. de Hingh, Jean‐Baptiste Delhorme, Abdelkader Taïbi, Laurent Villeneuve, Réa Lo Dico, Brendan Moran, Kim Govaerts, Oliver Zivanovic, Donal J. Brennan, Cédric Nadeau, Willemien J. van Driel, Naoual Bakrin, Pompiliu Piso, Victor J. Verwaal, Santiago González‐Moreno, Mohammad Alyami, Olivia Sgarbură, Beate Rau, Marcello Deraco, Olivier Gléhen
Abstract
The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.